File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Role of permanent pacing to prevent atrial fibrillation: Science Advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes research interdisciplinary Working Group, in collaboration with the Heart Rhythm Society

TitleRole of permanent pacing to prevent atrial fibrillation: Science Advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes research interdisciplinary Working Group, in collaboration with the Heart Rhythm Society
Authors
Issue Date2005
PublisherLippincott Williams & Wilkins. The Journal's web site is located at http://circ.ahajournals.org
Citation
Circulation, 2005, v. 111 n. 2, p. 240-243 How to Cite?
AbstractThis advisory summarizes the current database on pacing modalities and algorithms used to prevent and terminate atrial fibrillation (AF). On the basis of the evidence indicating that ventricular pacing is associated with a higher incidence of AF in patients with sinus node dysfunction, a patient who has a history of AF and needs a pacemaker for bradycardia should receive a physiological pacemaker (dual chamber or atrial) rather than a single-chamber ventricular pacemaker. For patients who need a dual-chamber pacemaker, efforts should be made to program the device to minimize the amount of ventricular pacing when atrioventricular conduction is intact. Many pacemakers and implantable defibrillators have features designed to prevent AF and to terminate AF with rapid atrial pacing. The evidence to support their use is limited, although these algorithms appear to be safe and usually add little additional cost. For patients who have a bradycardia indication for pacing and also have AF, no consistent data from large randomized trials support the use of alternative single-site atrial pacing, multisite right atrial pacing, biatrial pacing, overdrive pacing, or antitachycardia atrial pacing. Even fewer data support the use of atrial pacing in the management of AF in patients without symptomatic bradycardia. At present, permanent pacing to prevent AF is not indicated; however, additional studies are ongoing, which will help to clarify the role of permanent pacing for AF.
Persistent Identifierhttp://hdl.handle.net/10722/162777
ISSN
2015 Impact Factor: 17.047
2015 SCImago Journal Rankings: 7.853
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorKnight, BPen_US
dc.contributor.authorGersh, BJen_US
dc.contributor.authorCarlson, MDen_US
dc.contributor.authorFriedman, PAen_US
dc.contributor.authorMcnamara, RLen_US
dc.contributor.authorStrickberger, SAen_US
dc.contributor.authorTse, HFen_US
dc.contributor.authorWaldo, ALen_US
dc.date.accessioned2012-09-05T05:23:26Z-
dc.date.available2012-09-05T05:23:26Z-
dc.date.issued2005en_US
dc.identifier.citationCirculation, 2005, v. 111 n. 2, p. 240-243en_US
dc.identifier.issn0009-7322en_US
dc.identifier.urihttp://hdl.handle.net/10722/162777-
dc.description.abstractThis advisory summarizes the current database on pacing modalities and algorithms used to prevent and terminate atrial fibrillation (AF). On the basis of the evidence indicating that ventricular pacing is associated with a higher incidence of AF in patients with sinus node dysfunction, a patient who has a history of AF and needs a pacemaker for bradycardia should receive a physiological pacemaker (dual chamber or atrial) rather than a single-chamber ventricular pacemaker. For patients who need a dual-chamber pacemaker, efforts should be made to program the device to minimize the amount of ventricular pacing when atrioventricular conduction is intact. Many pacemakers and implantable defibrillators have features designed to prevent AF and to terminate AF with rapid atrial pacing. The evidence to support their use is limited, although these algorithms appear to be safe and usually add little additional cost. For patients who have a bradycardia indication for pacing and also have AF, no consistent data from large randomized trials support the use of alternative single-site atrial pacing, multisite right atrial pacing, biatrial pacing, overdrive pacing, or antitachycardia atrial pacing. Even fewer data support the use of atrial pacing in the management of AF in patients without symptomatic bradycardia. At present, permanent pacing to prevent AF is not indicated; however, additional studies are ongoing, which will help to clarify the role of permanent pacing for AF.en_US
dc.languageengen_US
dc.publisherLippincott Williams & Wilkins. The Journal's web site is located at http://circ.ahajournals.orgen_US
dc.relation.ispartofCirculationen_US
dc.subject.meshAlgorithmsen_US
dc.subject.meshAtrial Fibrillation - Complications - Physiopathology - Prevention & Control - Therapyen_US
dc.subject.meshBradycardia - Complications - Therapyen_US
dc.subject.meshCardiac Pacing, Artificial - Methodsen_US
dc.subject.meshHeart Conduction System - Physiopathologyen_US
dc.subject.meshHumansen_US
dc.subject.meshPacemaker, Artificialen_US
dc.subject.meshRandomized Controlled Trials As Topicen_US
dc.titleRole of permanent pacing to prevent atrial fibrillation: Science Advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes research interdisciplinary Working Group, in collaboration with the Heart Rhythm Societyen_US
dc.typeArticleen_US
dc.identifier.emailTse, HF:hftse@hkucc.hku.hken_US
dc.identifier.authorityTse, HF=rp00428en_US
dc.description.naturelink_to_OA_fulltexten_US
dc.identifier.doi10.1161/01.CIR.0000151800.84945.47en_US
dc.identifier.pmid15657388-
dc.identifier.scopuseid_2-s2.0-12344277382en_US
dc.identifier.hkuros115079-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-12344277382&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume111en_US
dc.identifier.issue2en_US
dc.identifier.spage240en_US
dc.identifier.epage243en_US
dc.identifier.isiWOS:000226365800019-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridKnight, BP=7201940628en_US
dc.identifier.scopusauthoridGersh, BJ=35371853600en_US
dc.identifier.scopusauthoridCarlson, MD=7201686978en_US
dc.identifier.scopusauthoridFriedman, PA=34975087100en_US
dc.identifier.scopusauthoridMcNamara, RL=7103138067en_US
dc.identifier.scopusauthoridStrickberger, SA=7005045293en_US
dc.identifier.scopusauthoridTse, HF=7006070805en_US
dc.identifier.scopusauthoridWaldo, AL=7102082668en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats